Biotech Startups
10,159 companies tagged Biotech, with their investors and founders.
Faction is a venture capital firm that invests in cryptocurrency and blockchain projects at the seed and series A stages, focusing on entrepreneurs building fundamental utility across the technology stack.
36 investors
Varda industrializes low Earth orbit by manufacturing pharmaceuticals and other specialized products in space, then returning them to Earth via reusable reentry capsules. The company develops both in-space production infrastructure and the vehicles needed to support commercial orbital manufacturing.
27 investors
Ginkgo Bioworks builds autonomous labs that accelerate bioengineering for applications in pharmaceutical, agricultural, and industrial biotechnology. The company serves biopharma, agritech, and industrial biotech companies seeking to engineer organisms at scale.
24 investors
AOA Dx develops a blood-based liquid biopsy platform using mass spectrometry and machine learning to detect ovarian cancer at early stages through tumor-associated biomarkers in serum. The company serves oncologists and patients in women's health diagnostics.
23 investors
Neurotechnology company developing implantable brain-computer interfaces for people with paralysis and vision loss.
23 investors
BillionToOne is a precision diagnostics company that uses molecular counting technology to develop non-invasive prenatal screening and liquid biopsy tests for early disease detection. The company focuses on making molecular diagnostics accurate, fast, and accessible to patients.
21 investors
Solugen develops a biomanufacturing platform using fermentation and bioprocessing technology to produce specialty chemicals at scale. The company serves customers in energy, chemicals, and related industries with cost-effective alternatives to traditional petrochemical-based manufacturing.
21 investors
Contraline develops new contraceptive and reproductive health technologies, with a focus on male contraception. The company works on translational reproductive biology research to bring new contraceptive options to market.
18 investors
Benchling provides a cloud-based R&D platform for life sciences, combining a collaborative electronic lab notebook, structured scientific data modeling, automated workflows, and AI tools. It serves scientists and biotech R&D teams working with biomolecules, small molecules, cell lines, and other research data.
17 investors
Paradromics develops a brain-computer interface (BCI) system, with FDA Breakthrough Device Designations for speech decoding and digital device control, and works with academic medical institutions on translational BCI research. The company builds implantable neurotechnology aimed at clinical applications.
17 investors
Recursion applies computational and data-driven approaches to biological science, aiming to accelerate drug discovery and develop new treatments. The company combines life scientists and software engineers to solve problems at the intersection of biology and technology.
17 investors
Upside Foods produces cultivated meat using cell-based technology. The company serves consumers and food companies seeking alternative protein sources in the meat industry.
17 investors
Freenome develops early-stage cancer detection technology using blood tests to identify cancer in its earliest, most treatable phases. The company serves healthcare providers and patients seeking preventive cancer screening solutions.
15 investors
Geltor uses a proprietary biodesign and precision fermentation platform to create and commercially produce novel protein ingredients, including collagens, for beauty and personal care formulators. Its process spans computational protein design, large-scale fermentation, purification, and claims substantiation to deliver animal-free, GMO-free protein ingredients.
15 investors
Science Corporation develops brain-computer interface and neural engineering technology to restore vision, cognition, and mobility to patients with debilitating conditions. The company also provides components and vertically integrated infrastructure through Science Foundry to support innovation across the neural technology industry.
15 investors
BlueNalu develops cell-cultivated seafood grown directly from fish cells in a controlled environment, aiming to supply seafood without harvesting it from the ocean. The company positions its products as an alternative to traditional fisheries to address global seafood supply gaps.
14 investors
GRAIL develops the Galleri blood test for multi-cancer early detection using next-generation sequencing and machine learning to screen for multiple deadly cancer types before symptoms appear. The test is offered by prescription in the United States and through partnerships with healthcare systems, insurance carriers, and diagnostic platforms.
14 investors
Mammoth Bio develops technology to read and write the code of life, operating in the biotechnology sector.
14 investors
Twist Bioscience develops a silicon-based synthetic DNA manufacturing platform that produces high-quality DNA, genes, and NGS reagents for customers in medicine, agriculture, and industrial chemicals. The platform enables faster and more affordable DNA synthesis at scale with customizable high-throughput capabilities.
14 investors
23andMe operates a research platform that collects genetic data from millions of users to advance genomic research and health discovery. The company enables individuals to learn about their genetic traits while contributing to medical research studies that benefit public health.
13 investors
Aether develops additives that blend into engineering-grade nylons to enable faster, high-throughput fused filament (FFF/FDM) 3D printing while maintaining mechanical strength and dimensional accuracy. Its products serve additive manufacturing users in production, field repair, and prototyping settings.
13 investors
Chai Discovery builds a computer-aided design suite using artificial intelligence to design new molecules and drugs. The platform enables pharmaceutical companies to discover and develop medicines more efficiently by learning the principles of biological structure and interaction.
13 investors
Finless Foods develops cell-cultivated seafood alternatives, starting with Pacific bluefin tuna, aimed at consumers seeking sustainable options that reduce pressure on wild fish stocks. The company uses cellular agriculture to produce cultured fish for the consumer food market.
13 investors
Gameto develops cell therapy and reproductive technologies to treat infertility and improve women's health outcomes. The company uses stem cell biology and in vitro maturation techniques to create innovative solutions for patients seeking family-building options.
13 investors